Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020067683 - NOVEL PROCESS FOR THE PREPARATION OF (+)-CIBENZOLINE SUCCINATE

Publication Number WO/2020/067683
Publication Date 02.04.2020
International Application No. PCT/KR2019/012267
International Filing Date 20.09.2019
IPC
C07D 233/06 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
233Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
04having one double bond between ring members or between a ring member and a non-ring member
06with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
C07C 55/10 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
55Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
02Dicarboxylic acids
10Succinic acid
A61K 31/4164 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
41641,3-Diazoles
A61P 9/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
06Antiarrhythmics
CPC
A61K 31/4164
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
41641,3-Diazoles
A61P 9/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
06Antiarrhythmics
C07C 55/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
55Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
02Dicarboxylic acids
10Succinic acid
C07D 233/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
233Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
04having one double bond between ring members or between a ring member and a non-ring member
06with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
Applicants
  • CELLTRION INC. [KR]/[KR]
Inventors
  • DESI REDDY, Srinivas Reddy
  • MATHAD, Vijayavitthal Thippannachar
  • RANE, Dnyandev Ragho
  • PATIL, Vikas Shivaji
Priority Data
IN20184103679028.09.2018IN
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NOVEL PROCESS FOR THE PREPARATION OF (+)-CIBENZOLINE SUCCINATE
(FR) NOUVEAU PROCÉDÉ DE PRÉPARATION DE SUCCINATE (+)-CIBENZOLINE
Abstract
(EN)
The present invention relates to a crystalline form of (+)-Cibenzoline succinate. The present invention is also related to a process for the preparation of (+)-Cibenzoline succinate with chiral purity greater than 99.9%. The present invention also provides a process for the preparation of (+)-Cibenzoline succinate and a crystalline form thereof.
(FR)
La présente invention concerne une forme cristalline du succinate (+)-Cibenzoline. La présente invention concerne également un procédé de préparation du succinate (+)-Cibenzoline avec une pureté chirale supérieure à 99,9 %. La présente invention concerne en outre un procédé de préparation du succinate (+)-Cibenzoline et d'une forme cristalline correspondante.
Latest bibliographic data on file with the International Bureau